Moleculin Biotech Chief Science Officer Donald H. Picker acquires common shares worth $129,999.75

Reuters2026/08/05 20:17

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Moleculin Biotech Chief Science Officer Donald H. Picker reported a purchase of 173,333 common shares, lifting direct ownership to 174,086 shares.
Picker also bought 519,999 Series I Warrants; he now holds 539,595 warrants tied to the same number of common shares.
The shares and accompanying warrants were bought in a public offering at a combined price of $0.75 per share with three warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-025927), on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Moleculin Biotech Chief Science Officer Donald H. Picker acquires common shares worth $129,999.75

You may also like

Crypto prices